EUPRAXIA PHARMACEUTICALS INC

Historical 13F Holders

Symbol
EPRX
CUSIP
29842P105
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 29842P105 since 12/18/2024, newest first.

Filer % of Class Filed
Manchester Management Co LLC 13G/A Amendment 3
4.5% 8/13/2026
Event 6/30/2026
Manchester Management Co LLC 13G/A Amendment 2
7.7% 5/12/2026
Event 3/31/2026
Joseph S. Freedman 13D/A Amendment 2 9.0% 3/16/2026
Event 3/13/2026
Manchester Management Co LLC 13G/A Amendment 1
9.2% 2/17/2026
Event 12/31/2025
Beutel, Goodman & Co Ltd. 13G 8.0% 11/14/2025
Event 9/30/2025
Robert Disbrow 13G/A Amendment 1 7.0% 11/14/2025
Event 9/30/2025
Manchester Management Co LLC 13G
10.9% 11/13/2025
Event 12/31/2024
Joseph S. Freedman 13D/A Amendment 1 10.2% 9/26/2025
Event 9/24/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 79.7 k $561 k
2026 Q2 67 24.8 M $164 M
2026 Q1 55 22.2 M $158 M
2025 Q4 36 13.9 M $105 M
2025 Q3 28 12.8 M $75.4 M
2025 Q2 16 2.40 M $13.4 M
2025 Q1 12 2.17 M $7.09 M
2024 Q4 10 1.83 M $5.63 M
2024 Q3 9 1.80 M $4.55 M
2024 Q2 10 1.73 M $4.44 M